📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults (2020)

First Author: Ward H

Attributed to: Centre for Global Infectious Disease Analysis, Imperial College London (GIDA) - COVID-19 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2020.08.12.20173690

Publication URI: http://dx.doi.org/10.1101/2020.08.12.20173690

Type: Preprint